Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Guelph

$21,395.00

Post genomic structural and functional aspects of antibody in heath and disease

EF 2011-12

Résumé
For host defence, disease prevention and therapy, knowledge of the immune system and its regulation in health and disease is of fundamental importance. Towards this goal, our research is focused on 'antibody genetics and autoimmunity'. We made an original discovery of unique functional IgM antibodies in cattle, the largest known to exist in a species. This offers opportunity to develop novel antibody engineering strategies for prevention of those diseases where conventional therapies fail, e.g., cancer, autoimmune diseases and viral infections. My proposed research aims at defining 'structure-function' relationships of these novel types of antibodies and, also to develop a vaccine against bovine leukemia virus. These studies also involve understanding the development of the neonatal immune system aimed at strengthening the host defence of newborns against infections. Other studies are focused on the origin of autoantibodies that cause systemic autoimmune disease, such as Lupus and arthritis. We have observed that pathogenic autoantibodies originate from the impaired development of the antibody repertoire at newborn stage. The role of B-cell selection in generating systemic autoimmune disease is not well understood. The proposed studies are aimed at identifying the anatomical location where white blood cells (B-cells) producing pathogenic autoantibodies, especially of the IgM type, originate so that these could be targeted for elimination by therapeutic intervention in patients afflicted with autoimmune disease. The IgM autoantibody type is studied since these appear first and initiate autoimmune disease. Significance: Studies of 'structure-function' of cattle antibodies will advance engineering of antibodies for application in diagnosis, vaccine development and immunotherapy across species including humans, apart from strengthening immunity in the newborns. The vaccine against bovine leukemia virus will prevent economic losses to cattle industry. Knowledge of the origin of IgM autoantibodies that appear first in autoimmune disease will permit detection and prevention of disease progression in the early stages.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
121465-2007
Name nom
Kaushik, Azad
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2007
Award amount
21395
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
5
Nb partie
5
Application title
Post genomic structural and functional aspects of antibody in heath and disease
Keyword
NSERC
Application summary
For host defence, disease prevention and therapy, knowledge of the immune system and its regulation in health and disease is of fundamental importance. Towards this goal, our research is focused on 'antibody genetics and autoimmunity'. We made an original discovery of unique functional IgM antibodies in cattle, the largest known to exist in a species. This offers opportunity to develop novel antibody engineering strategies for prevention of those diseases where conventional therapies fail, e.g., cancer, autoimmune diseases and viral infections. My proposed research aims at defining 'structure-function' relationships of these novel types of antibodies and, also to develop a vaccine against bovine leukemia virus. These studies also involve understanding the development of the neonatal immune system aimed at strengthening the host defence of newborns against infections. Other studies are focused on the origin of autoantibodies that cause systemic autoimmune disease, such as Lupus and arthritis. We have observed that pathogenic autoantibodies originate from the impaired development of the antibody repertoire at newborn stage. The role of B-cell selection in generating systemic autoimmune disease is not well understood. The proposed studies are aimed at identifying the anatomical location where white blood cells (B-cells) producing pathogenic autoantibodies, especially of the IgM type, originate so that these could be targeted for elimination by therapeutic intervention in patients afflicted with autoimmune disease. The IgM autoantibody type is studied since these appear first and initiate autoimmune disease. Significance: Studies of 'structure-function' of cattle antibodies will advance engineering of antibodies for application in diagnosis, vaccine development and immunotherapy across species including humans, apart from strengthening immunity in the newborns. The vaccine against bovine leukemia virus will prevent economic losses to cattle industry. Knowledge of the origin of IgM autoantibodies that appear first in autoimmune disease will permit detection and prevention of disease progression in the early stages.